Celldex Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CLDX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 55.34 M32.5 M54.4 M44 M48.6 M63.95 M 210.94 M Cash from investing activities -47.76 M-24.05 M42.95 M49.85 M60.85 M55.42 M 209.07 M Cash from financing activities 1.24 M386 K202 K63 K774 K1.35 M 2.39 M Free cash flow 54.79 M31.74 M54.13 M43.27 M48.16 M62.66 M 208.23 M

Notizie

Celldex presenta dati di fase 2 per il trattamento dell’orticaria cronica

Celldex presents phase 2 data for chronic urticaria treatment

Celldex Therapeutics Stock Earns 88 RS Rating

Gli EPS di Celldex Therapeutics hanno mancato le aspettative per 0,21$, il fatturato appena sotto le previsioni

Celldex Therapeutics earnings missed by $0.21, revenue fell short of estimates

Le azioni di Celldex Therapeutics raggiungono il massimo di 52 settimane a 30,66 USD

Celldex Therapeutics stock hits 52-week high at 30.66 USD

Stifel conferma il rating su Celldex Therapeutics per i progressi negli studi clinici

Stifel reiterates Celldex Therapeutics stock rating on trial progress

Celldex completa l’arruolamento di Fase 3 per il trattamento della CSU in anticipo

Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule

Cantor Fitzgerald riconferma il rating Overweight per le azioni Celldex